← All investors

Sphera Funds Management

3 portfolio companies · 1 on the map · $360.1M raised · 1 cities

Portfolio map

1 Sphera Funds Management portfolio company on the map.

Portfolio companies

Stoke Therapeutics
Bedford
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Biotechnology Research$360.1MEst. 2017

More portfolio companies

2 more Sphera Funds Management investments we track beyond the map.

Portfolio map

1 Sphera Funds Management portfolio company on the map.

Sphera Funds Management portfolio | CleraMap